3 ‘Strong Buy’ Dividend Aristocrat Stocks for Dependable Income, 8/5/26
For investors seeking dependable dividend income, International Business Machines ($IBM), Johnson & Johnson ($JNJ), and Coca-Cola ($KO) stand out. ...
Johnson & Johnson (JNJ)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Fisher Asset Management Ken Fisher | 13,307,056 | $3,379,593,434 | +44% | 1.01% |
| 2. | Markel Gayner Asset Management Tom Gayner | 610,800 | $155,124,875 | 1.18% | |
| 3. | RWC Asset Management Tord Stallvik (Ceo) | 262,139 | $66,575,442 | +2% | 2.52% |
| 4. | Levin Capital Strategies John A. Levin | 206,094 | $52,341,566 | -1% | 3.51% |
| 5. | 189,700 | $48,178,109 | +36% | 0.17% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $206.15 | 1,250 | $257,687.50 | 1,849 | 2025-11-26 | Filing | |
| $145.53 | 100 | $14,553.00 | 250 | 2024-04-30 | Filing | |
| $147.22 | 1,000 | $147,220.00 | 1,000 | 2024-12-12 | Filing | |
| $127.69 | 500 | $63,843.00 | 16,030 | 2020-03-13 | Filing | |
| $141.28 | 5,000 | $706,399.00 | 5,000 | 2019-12-13 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $251.27 | 23,054 | $5,792,686.36 | 23,003 | 2026-07-20 | Filing | |
| $241.15 | 10,000 | $2,411,500.00 | 114,288 | 2026-06-11 | Filing | |
| $247.87 | 4,075 | $1,010,070.25 | 23,682 | 2026-02-27 | Filing | |
| $245.66 | 1,322 | $324,762.52 | 25,447 | 2026-02-20 | Filing | |
| $242.70 | 20,521 | $4,980,446.70 | 25,698 | 2026-02-17 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 10,539,098 | $2,703,293,314 | 0.86% | |
| 2. | 6,776,620 | $1,721,057,957 | 3.85% | |
| 3. | 5,660,854 | $1,437,687,090 | 0.82% | |
| 4. | 4,910,996 | $1,247,239,584 | 0.29% | |
| 5. | 4,891,125 | $1,242,199,016 | 1.08% |
News See All
Broadcom Stock (AVGO) Falls as Goldman Sachs Removes It From the ‘Conviction List’
The bank sees the market rally broadening out beyond AI.
Jim Cramer Analyzes Johnson & Johnson (JNJ) After Surgical Robotics Milestone
Jim Cramer celebrated a dramatic pivot in market sentiment surrounding Johnson & Johnson (NYSE:JNJ) during Mad Money’s July 23 episode.
Johnson & Johnson vs. Danaher: Which Healthcare Stock Looks Better Positioned Following Earnings?
Johnson & Johnson (NYSE:JNJ) delivered strong fiscal Q2 2026 results, with sales for the quarter growing nearly 7% to $25.31 billion, above analysts' average estimate of about $25.05 billion.
Johnson & Johnson (JNJ) Raised Its Outlook. Is It the Better Healthcare Stock to Own After Earnings?
Johnson & Johnson (NYSE:JNJ) delivered strong fiscal Q2 2026 results, with sales for the quarter growing nearly 7% to $25.31 billion, above analysts' average estimate of about $25.05 billion.
President Trump Loves Johnson & Johnson (JNJ), But Insiders Are Selling
Johnson & Johnson (NYSE:JNJ) is one of the health care names that showed up in President Donald Trump's financial disclosures released earlier this year.
Jim Cramer Said To Buy Johnson & Johnson (NYSE:JNJ)'s Shares - Here's What Happened Next
Healthcare giant Johnson & Johnson (NYSE:JNJ) is one of Jim Cramer's top healthcare stocks even though the shares have been lackluster.
Jim Cramer's 22 Stock Calls Including Meta, NVIDIA, and AI Opportunities in the Neocloud Space
In this article, we will look at Jim Cramer’s stock calls on Mad Money, as he highlighted the AI opportunities in neoclouds.
Jim Cramer's Biggest Winners to Buy: Top 20 AI & Other Stocks He Got Right in 2026
In this article, we will discuss: Jim Cramer's Biggest Winners to Buy: Top 20 AI & Other Stocks He Got Right in 2026.
Billionaire Cliff Asness’ Top 10 Healthcare Stock Picks
Cliff Asness is a billionaire investor and the co-founder and chief investment officer of AQR Capital Management, a quantitative hedge fund.
Hedge Fund Resource Center